Maximillian Licona

Representative Experience

• Represented two venture capital funds as lead investors in an over $1.5 billion Series E financing of an AI cloud infrastructure company.
• Represented a health care technology company focused on behavioral health engagement in connection with multiple convertible note financings and general corporate governance matters.
• Represented a venture capital fund as lead investor in a $300 million Series C financing of a deep learning infrastructure company.
• Represented a fintech and crypto counterparty platform in various Series Seed and note financings, and general corporate governance matters.
• Represented a venture capital fund as lead investor in a $200 million Series C financing of an artificial intelligence developer platform company.
• Represented a foreign exchange trading platform in a Series A extension financing and general corporate governance matters.
• Represented a venture capital fund as lead investor in a $221 million Series C financing of a supply chain intelligence platform.
• Represented a real estate technology company in a Series B financing, with a corresponding rights offering, and general corporate governance matters.
• Represented a venture capital fund as lead investor in a $200 million Series F financing of a technology-based defense company.
• Represented spirits industry companies in equity and debt financings and general corporate governance matters.
• Represented a venture capital fund as lead investor in a $200 million Series C financing of a cloud computing hardware and software company.
• Represented a venture capital fund as lead investor in a $174 million Series C financing of a photonic computing and optical data transfer company.
• Represented a venture capital fund as lead investor in a $150 million Series D financing of a rocket and space transportation company.
• Represented a venture capital fund as lead investor in an $80 million Series B financing of a precision manufacturing technology company.
• Represented a venture capital fund as lead investor in an $80 million Series B financing of an enterprise AI and knowledge management company, along with a follow $15 million SAFE financing.
• Represented a venture capital fund as lead investor in a $70 million extension of the Series C round of a critical infrastructure robotics company.
• Represented a venture capital fund as lead investor in an $85 million extension of the Series D round of a quantum computing company.
• Represented a venture capital fund as lead investor in a $60 million Series C-2 financing of a satellite technology company.
• Represented a venture capital fund as lead investor in a $57 million extension of the Series E round of a technology-based defense company.
• Represented a venture capital fund as lead investor in a $50 million Series A financing of a space services company.
• Represented a venture capital fund in a $30 million convertible note financing of a technology-based defense and AI company, subsequently converting into Series D-1 preferred stock and later as a co-lead investor in a follow-on $55 million Series D-2 financing.
• Represented a health care-focused investment fund in a $12 million Series A financing and a $11.1 million Series A-3 financing of a health care technology company focused on senior care analytics.
• Represented a proprietary trading firm as lead investor in a $12 million Series A financing of a designated contract market platform.